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Abstract
Objective: This study determines the roles of tumor necrosis factor-a (TNFa) and lymphotoxin-a (LTa) in post-myocardial
infarction (post-MI) cardiac injury, and identifies the TNF receptor type responsible for TNFa- and LTa-mediated cardiac
injury.
Methods and Results: Adult male wild type (WT), TNFa2/2, LTa2/2, TNFR12/2, and TNFR22/2mice were subjected to MI via
coronary artery occlusion. Functional, histological, and biochemical analyses were performed 1 to 7 days post-MI. In WT
mice, MI significantly increased both TNFa and LTa levels in plasma, but in distinct temporal manner. Plasma TNFa peaked
1 day after MI, and decreased toward baseline 3 days after MI. In contrast, plasma LTa became significantly increased 3 days
post-MI, and remained elevated thereafter. TNFa deletion significantly improved cardiac function 3 days, but not 7 days,
after MI. In contrast, LTa deletion had no effect upon cardiac dysfunction 3 days after MI, but improved cardiac function
7 days after MI. More importantly, knockout of TNFR1 and TNFR2 had opposite effects upon post-MI cardiac dysfunction,
which was markedly attenuated by TNFR1 deletion (P,0.01 vs. WT), but exacerbated by TNFR2 deletion (P,0.05 vs. WT).
Conclusion: Our study demonstrates that TNFa and LTa overproduction contribute to early and late cardiac dysfunction
after MI, respectively. We provide clear evidence that both TNFa and LTa mediate post-MI cardiac dysfunction via TNFR1
stimulation, whereas TNFR2 activation is cardioprotective against ischemic injury. Simultaneous inhibition of TNFa and LTa
or specific TNFR1 function blockade may represent superior cardioprotective approaches over general TNF activity
suppression.
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Introduction
Cardiac disease remains a leading cause of mortality worldwide.
Although improved reperfusion strategies have decreased death
rates after acute myocardial infarction (MI), both incidence and
prevalence of post-MI heart failure have increased in recent years
[1]. Defining the molecular mechanisms underlying the transition
from adaptive to maladaptive remodeling in the post-MI heart,
and identifying novel therapeutic strategies capable of blocking/
reversing such conversion, are therefore in great need.
TNFa is a pro-oxidative cytokine exerting a wide range of
biological activities. Plasma TNF-a levels are significantly
increased in patients with cardiovascular disease, particularly
myocardial infarction (MI) and heart failure [2]. In vitro
experimental studies demonstrate that TNFa suppresses cardiac
contractility [3], provokes myocardial hypertrophy [4], and
induces apoptosis in cardiac myocytes [5]. Generally regarded a
cardiotoxic molecule, TNFa has been investigated as a target for
attenuating cardiovascular injury. Unfortunately, neither soluble
antibodies against the TNF receptor [6] nor TNF itself [7] have
yielded promising clinical trial results. Mechanisms responsible for
the divergent results obtained from experimental models versus
clinical patients remain unclear. Recent experimental studies
demonstrate that activation of TNF receptor 1 (TNFR1) and TNF
receptor 2 (TNFR2) initiate different/opposite biological effects
[8]. However, the roles of TNFR1 and TNFR2 activation by
different cytokines produced during different time course after MI
remain incompletely understood.
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Lymphotoxin-a (LTa, also known as TNF-b) is a member of the
TNF family, synthesized primarily by activated T and B
lymphocytes [9]. Previous studies demonstrate LTa shares the
same membrane receptors as TNFa, exerting biological effect
largely via TNFR1 and TNFR2 activation [9]. A recent clinical
epidemiological study reveals variations in the gene encoding LTa
(thereby affecting its expression and biological function) confers
myocardial infarction risk [10]. In vitro experiments demonstrate
LTa upregulates adhesion molecule expression [11], and LTa
deletion reduces atherosclerosis in mice [12]. However, no direct
evidence linking LTa with myocardial ischemic injury currently
exists, and the role of LTa in post-MI cardiac injury remains
undefined.
Therefore, the aims of the present study were: 1) to compare the
role of TNFa and LTa in post-MI cardiac injury; and 2) to
identify the TNFa receptor subtype responsible for TNFa- and
LTa-mediated cardiac injury.
Materials and Methods
Animals
Wild type (WT, C57BL/6), TNFa gene knockout (TNFa2/2),
LTa gene knockout (LTa2/2), TNF receptor 1 knockout
(TNFR12/2), and TNF receptor 2 knockout (TNFR22/2) mice
were purchased from Jackson Laboratory (Bar Harbor, ME), and
confirmed by specific primer genotyping. All experiments were
performed in adherence with the National Institutes of Health
Guidelines on the Use of Laboratory Animals, and were approved by the
Thomas Jefferson University Committee on Animal Care.
Experimental Protocols
Male adult mice were anesthetized with 2% isoflurane.
Myocardial infarction (MI) was produced by temporarily exteri-
orizing the heart via left thoracic incision, and placing a 6–0 silk
suture slipknot around the left anterior descending coronary artery
[13]. Sham-operated control mice (sham MI) underwent the same
surgical procedures, except the suture placed under the left
coronary artery was not tied. Plasma TNFa, LTa, cardiac
function, and cardiac injury were determined as described below.
Determination of Plasma TNF-a and LTa Concentrations
After 1, 3, or 7 days of MI or sham MI, animals were re-
anesthetized (2% isoflurane). Left ventricular blood was centri-
fuged, yielding plasma. Plasma TNF-a and LTa concentrations
were determined by mouse TNF-a and LTa ELISA kits
(BioLegend, San Diego, CA) per manufacturer’s instructions.
Determination of Cardiac Function
After 3 or 7 days of MI or sham MI, animals were re-
anesthetized. Parasternal short axis m-mode images of the
murine left ventricle, obtained via VisualSonics 770 machine
with 25-MHz linear transducer, recorded heart rate (HR), end-
Figure 1. Time course of post-MI (A) TNFa and (B) LTa
production. N=14–16/group. *P,0.05, **P,0.01 vs. control.
doi:10.1371/journal.pone.0060227.g001
Figure 2. Effect of (A) TNFa and (B) LTa gene deletion upon left
ventricular ejection fraction (LVEF) determined 3 or 7 days
after MI. N=14–16/group. *P,0.05 vs. WT at the same time point.
doi:10.1371/journal.pone.0060227.g002
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diastolic dimension (EDD), end-systolic dimension (ESD), and
anterior/posterior wall thickness. All echocardiographic param-
eters were averaged over 10–20 cardiac cycles. Calculated values
included left ventricular ejection fraction (LVEF), fractional
shortening (FS), and average wall thickness. At the end of 7-day
observation period, cardiac function was also determined by left
ventricular (LV) catheterization (1.2-Fr micromanometer, Millar
Instruments, Houston, TX) prior to animal sacrifice. Echocardi-
ography and LV catheterization have been described in detail
previously [14;15].
Measurement of Infarct Size
Hearts were preserved in 10% formalin overnight, and
embedded in paraffin. Cardiac regions proximal of the ligated
coronary artery (including left and right atria) were dissected away.
Distal remaining cardiac portions were transversely sliced from
apex to base, in 6 mm thick sections, with 900 mm between each
section. All sections were mounted upon glass slides and stained
with Masson trichrome stain (MarketLab Inc, Caledonia, MI). All
histological sections were examined via Olympus BX51 micro-
scope (26 objective lens). Images were captured via QIMAGINE
CCD camera, utilizing IPLab 4.0 software. The LV myocardial
midline was drawn centrally between the epicardial and endocar-
dial surfaces. Midline circumference was measured. Infarct size
was calculated by dividing midline infarct lengths (Masson blue
staining) by midline circumferences, and multiplying by 100%.
Results from all slides obtained in the same heart were averaged,
and counted as n = 1.
Figure 3. Effect of TNFR gene deletion upon cardiac function 3
days following MI. Genetic deletion of TNFR1, but not TNFR2,
significantly attenuated post-MI (at day 3) cardiac dysfunction, as
determined by left ventricular ejection fraction (LVEF, B) and fractional
shortening (FS, B). N = 15–16/group. **P,0.01 vs. own sham MI control;
$P,0.05, $$P,0.01 vs. WT at the same time point.
doi:10.1371/journal.pone.0060227.g003
Figure 4. Effect of TNFR gene deletion upon cardiac function
7 days following MI. TNFR1 gene deletion significantly improved
cardiac function 7 days post-MI, as evidenced by reduced left
ventricular end diastolic pressure (LVEDP, A) and increased 6dP/dtmax
(B, C). In contrast, TNFR2 gene deletion further exacerbated cardiac
dysfunction (B, C). N = 14–15/group. *P,0.05, **P,0.01 vs. own sham
MI control; $P,0.05, $$P,0.01 vs. WT at the same time point.
doi:10.1371/journal.pone.0060227.g004
TNF Receptors and Adiponectin Expression
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Histological Analysis of Myocardial Fibrosis
Each heart was processed as described above, and stained with
Masson’s trichrome 2000 stain. Slides were examined via
Olympus IX51 microscope (206 objective lens). 5 remote, non-
ischemic area images were captured. Collagen-positive areas were
calculated by Image IPlab 4.0 software. Percent fibrosis was
expressed as the ratio of fibrotic area (blue) to total LV area [16].
Average blue area percentage was calculated in at least 5 different
hearts.
Statistical Analysis
All values in the text and figures are presented as means6 SEM
of n independent experiments. Data were subjected to one or two-
way (where appropriate) ANOVA followed by Bonferoni correc-
tion for post-hoc test. Probabilities of 0.05 or less were considered
statistically significant.
Results
Plasma TNFa and LTa Significantly Increase After MI, but
Follow Different Time Courses
Plasma TNFa levels swiftly peaked 1 day after MI, and
gradually reduced thereafter. In contrast, plasma LTa rise did
not significantly occur until 3 days after MI, but remained
significantly greater than control 7 days after MI (Figure 1).
Genetic Deletion of TNFa and LTa Exerted Distinct
Cardioprotection at Different Time Course After MI
TNFa knockout had no significant effect upon LV function
during basal conditions (Figure 2A). However, 3 days after MI,
TNFa knockout mice exhibited significantly improved cardiac
function compared to WT. However, TNFa knockout was only
transiently cardioprotective. 7 days after MI, no difference in LV
function was observed between TNFa knockout mice and control.
LTa knockout did not affect LVEF before MI, and only slightly
increased LVEF 3 days after MI (P.0.05). However, LTa
knockout mice did not exhibit continuous deterioration of cardiac
function, as observed in WT animals. 7 days after MI, LVEF was
significantly greater in LTa knockout mice compared to WT
(Figure 2B).
TNFR1 and TNFR2 Knockout had Opposite Effect Upon
Post-MI Cardiac Dysfunction
Having demonstrated that TNFa and LTa knockout improved
cardiac function at different time courses following MI, we further
determined the contribution of TNFa receptor types (TNFR1 and
TNFR2) to cardiac injury mediated by TNFa/LTa. Plasma
TNFa and LTa concentration, as well as the effect of TNFR1 and
TNFR2 deletion upon post-MI cardiac function was determined
via echocardiography and left ventricular catheterization, 3 and
Table 1. Plasma TNFa and LTa Levels in Different Groups Investigated.
TNFa (pg/ml) LTa (pg/ml)
Post-MI(d) 0 1 3 7 0 1 3 7
WT 3662.9 7263.9** 6864.1** 4763.2* 16.362.1 24.261.4 64.963.9** 60.664.2**
TNFR1KO 3363.1 6663.8** 6564.2** 4663.9* 15.762.2 23.561.8 66.462.9** 59.763.9**
TNFR2KO 3763.9 8164.2** 7963.8** 5363.1* 16.862.4 25.361.9 67.463.1** 60.964.3**
WT=Wild type; TNFR1KO= TNF receptor 1 knockout; TNFR2KO= TNF receptor 2 knockout; N = 14–16/group. *P,0.05, **P,0.01 vs. day 1 post-MI.
doi:10.1371/journal.pone.0060227.t001
Figure 5. Effect of TNFR gene deletion upon infarct size
following MI. TNFR1 and TNFR2 gene deletion had opposite effects
upon infarct size (A) and interstitial fibrosis in remote non-ischemic
regions (B). N = 9–11/group. $P,0.05 vs. WT. All results were obtained
from animals subjected to 7 days of MI.
doi:10.1371/journal.pone.0060227.g005
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7 days after MI respectively. Knockout either TNFR1 or TNFR2
had no significant impact on plasma TNFa and LTa before or
after MI (Table 1). In sham MI control animals, no significant
difference in cardiac function between groups was observed
(Figures 3 and 4, left three bars). 3 days post-MI, LVEF and FS
were significantly decreased in all three groups compared to
respective control (*P,0.05, **P,0.01). However, cardiac
dysfunction was significantly attenuated ($P,0.05, $$P,0.01) in
TNFR12/2 mice compared WT (Figure 4). Mildly poorer cardiac
dysfunction was observed in TNFR22/2 mice, but not to
statistically significant degree compared to WT (Figure 3).
Consistent with echocardiographic results obtained 3 days post-
MI, cardiac dysfunction was significantly attenuated in TNFR12/
2 mice compared to WT ($$P,0.01) 7 days post-MI, evidenced by
decreased LVEDP (Figure 4A) and increased 6dP/dtmax
(Figure 4B, C). Although no significant difference in LVEDP
between TNFR22/2 and WT was observed, TNFR22/2 mice
exhibited significantly decreased 6dP/dtmax ($P,0.05).
TNFR1 and TNFR2 Knockout had Opposite Effects upon
Infarct Size and Pathological Remodeling
To determine the impact of TNFR1 and TNFR2 deletion upon
MI injury at the cellular level, two additional outcomes were
measured 7 days after MI. Myocardial infarct size was significantly
reduced in TNFR12/2 mice compared to WT ($P,0.05,
Figure 5A). In contrast, TNFR2 deletion further increased infarct
size ($P,0.05). Moreover, TNFR1 and TNFR2 deletion had
opposite effects upon interstitial fibrosis in non-ischemic remote
regions (Figure 5B), as interstitial fibrosis was significantly reduced
in TNFR12/2 mice, but exacerbated in TNFR22/2 mice
($P,0.05).
Discussion
We present several important observations in the current study.
We provide direct evidence that TNFa and LTa contribute to
post-MI cardiac injury via distinctive time courses. TNFa is a
prominent element within the ‘‘cytokine hypothesis’’ of myocardial
ischemic heart disease [2]. Transgenic mice with cardiac-specific
overexpression of TNFa develop cardiac dilatation, interstitial
infiltrates, abnormal calcium homeostasis, increased apoptosis,
extracellular matrix remodeling, ventricular arrhythmias, and
early death [17]. Moreover, many experimental studies have
demonstrated that inhibiting TNFa production or blocking
TNFa-initiated intracellular signaling attenuates ischemic myo-
cardial injury [18]. However, anti-cytokines have not proven
clinically efficacious in chronic heart failure patients. Such
disparity illustrates our incomplete understanding of TNFa within
heart failure pathophysiology. The current study confirms TNFa
overproduction occurs following MI in burst fashion, rising
quickly, but lasting transiently. In contrast, no significant LTa
overproduction develops until 3 days after MI. However, plasma
LTa concentration remained significantly greater than control
even 7 days after MI. More importantly, TNFa-knockout
significantly improved cardiac function during the early phase of
MI, whereas LTa-knockout selectively augmented cardiac func-
tion during the late stage of MI. These results possibly explain the
efficacy discrepancy of anti-TNFa treatment post-MI between
acute experimental models and chronic clinical heart failure
patients.
LTa, a member of the TNF family, is synthesized primarily by
activated T and B lymphocytes [9]. It is expressed in either
secreted or membrane-bound form, each exhibiting different
affinity for various receptors. The secreted soluble homotrimeric
form binds to both TNFR1 and TNFR2 receptors with high
affinity, whereas the transmembrane heterotrimeric form (one
LTa plus two LTb) selectively binds the LTb receptor (LTbR)
with high specificity. LTa mediates various inflammatory,
immunostimulatory, and antiviral responses, influences cell death
or differentiation, and provides a communicative link between
lymphocytes and stromal cells [9]. Several genetic and clinical
studies demonstrate that variations in the gene encoding LTa
(consequently affecting its expression and biological function)
contribute to the risk of coronary artery disease, myocardial
infarction, aortic aneurysm formation, and cerebral infarction
[19;20]. Recent clinical studies demonstrate LTa gene variability
is also associated with metabolic syndrome features, including
increased C-reactive protein, hyperinsulinemia, and dyslipidemia
[21]. Our current study demonstrates for the first time that LTa
knockout significantly improves cardiac function 7 days after MI,
providing direct evidence that LTa overproduction plays a
causative role in post-MI cardiac injury. Mechanisms responsible
for LTa-induced cardiac injury are likely complex and multifac-
torial. Previous in vitro studies associate LTa-induced gene
expression with signal transduction, cell adhesion and chemoat-
traction, such as the nuclear factor of kappa light polypeptide gene
enhancer in B-cells (NFkB), endothelial adhesion molecule 1 (E-
Selectin), vascular cell adhesion molecule 1 (VCAM1), and
monocyte chemotactic protein 1 (MCP1) [11]. As inflammation
plays a significant role in post-MI pathologic remodeling,
inhibiting LTa may attenuate the inflammatory response,
preserving cardiac function.
T lymphocytes are pathogenic during post-MI injury. Deletion
of recombination-activating gene (RAG12/2), a protein necessary
for immunoglobulin and T-cell receptor gene recombination,
significantly reduced infarct size after MI/R [22]. This protective
effect was reversed by reconstitution of RAG12/2 mice by
adoptive transfer with CD4+ T cells. Moreover, CD4+ depleted
mice, but not CD8+ depleted mice, have significantly decreased
infarct size compared to control mice [22], further supporting the
deleterious role of CD4+ T cells during post-MI injury. As LTa is
synthesized primarily by activated T lymphocytes, our current
study provides data consistent with such lines of evidence, and
suggests blockade of LTa overproduction from activated T cells
may be, at least partly, responsible for the cardioprotection
observed in the RAG12/2 and CD4+ T-cell depleted state.
Emerging evidence indicates that TNFR2 activation by TNFa
exerts opposite biologic effects as TNFR1 activation. Greater TNFa
concentrations and cardiomyocyte TNFR1 activation are detri-
mental, whereas lower TNFa concentrations and cardiomyocyte
TNFR2 activation are protective. TNFR12/2 reduces apoptosis,
attenuates hypertrophy, improves contractile function, promotes
angiogenesis, and improves survival [23–26]. In contrast, TNFR22/
2 exacerbates MI injury [23;25–27]. Recent studies confirm the
opposite effects of TNFR1/TNFR2 activation during MI injury
result from their opposing regulatory effects upon NF-kB. Specif-
ically, TNFR1 deletion diminishes MI-induced NF-kB activation,
whereas TNFR2 deletion augments MI-induced NF-kB activation
[26]. Additionally, TNFa effects may depend upon its concentra-
tion, duration of exposure, and localization. Therefore, it is not
surprising that clinical chronic heart failure trials, employing
compounds antagonizing TNFa (including the TNFa-binding
antibody infliximab and the soluble recombinant TNFa-receptor
etanercept) revealed disappointing results [28]. The current study
supports the opposite roles of TNFR1 and TNFR2 in post-MI
injury.More importantly, we demonstrate thatTNFa knockout only
improves cardiac function during the early post-MI phase, whereas
LTa knockout only improves late post-MI cardiac function. TNFR1
TNF Receptors and Adiponectin Expression
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knockout protects against injury during the entire 7-day post-MI
period. Our results suggest both TNFa and LTa mediate cardiac
injury via TNFR1 activation.
In summary, the current study provides the first direct evidence
that LTa overproduction post-MI contributes to MI/R injury via
TNFR1 activation. In contrast, TNFR2 activation protects against
MI/R injury. Simultaneous inhibition of TNFa and LTa or specific
TNFR1 function blockade may represent superior cardioprotective
approaches over general TNF activity suppression.
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